Compare Las Vegas Sands Corp. (LVS) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Las Vegas Sands Corp. vs Tenet Healthcare Corporation — how do they compare? Las Vegas Sands Corp. trades at $36.41 (market cap $23.19B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Las Vegas Sands Corp. and Tenet Healthcare Corporation are close in size by market cap, and Las Vegas Sands Corp. pays a 3.35% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Las Vegas Sands Corp. for 72 Days and Tenet Healthcare Corporation for 15 Days on average.
| LVS | THC | |
|---|---|---|
Market Cap | $23.19B | $20.92B |
Volume | 4,822,073 | 455,764 |
Sector | Consumer Cyclical | Health |
52-Week High | $69.49 | $280.77 |
52-Week Low | $35.81 | $161.37 |
Typical Hold Time | 72 Days | 15 Days |
Enterprise Value | $35.08B | $32.00B |
Dividend Yield | 3.35% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LVS trades at $35.81, down 1.38% today, with a bearish technical signal from moving averages but bullish oscillators. The company reported revenue of $13.02B in 2025 with a net income margin of 12.59%, and recent earnings show mixed results with a Q2 2026 miss. Analysts maintain a strong buy consensus with a $59.78 price target, indicating significant upside potential from current levels.
The outlook for LVS is positive based on solid fundamentals and analyst optimism, but risks include high debt levels and reliance on Macao's tourism sector. Near-term performance may hinge on Q3 2026 earnings and ongoing stock repurchases, while long-term growth is supported by non-gaming expansions and community initiatives in Macao.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Las Vegas Sands Corp.
Las Vegas Sands is the world's largest operator of fully integrated resorts, featuring casino, hotel, entertainment, food and beverage, retail, and convention center operations. The company owns the Venetian Macao, Sands Macao, Londoner, Four Seasons Hotel Macao, and Parisian in Macao, and the Marina Bay Sands resort in Singapore. Its Venetian and Palazzo Las Vegas in the U.S. asets were sold to Apollo and VICI for $6.25 billion in 2022. We expect Sands to open a fourth tower in Singapore in 2026. After the sale of its Vegas assets, the company will generate all its EBITDA from Asia, with its casino operations generating the majority of sales.
Read more on LVS →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
